ESC 365 - Will ACE inhibitors be abandoned in the treatment of HFrEF?

ESC Premium Access

Will ACE inhibitors be abandoned in the treatment of HFrEF?

Session: The future therapy of heart failure: shall we find the answers in the crystal ball?

Topic: AHF - Drug treatment

Speaker: Professor J. McMurray (Glasgow, GB)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

110 presentations

7 followers

3 more presentations in this session

Should beta-blockers be stopped in HFrEF and atrial fibrillation?

Speaker: Professor T. McDonagh (London, GB)

Will we use VADs to recover the failing heart in the future?

Speaker: Doctor S. Drakos (Salt Lake City, US)

The path to leadless CRT.

Speaker: Professor J. Cleland (Glasgow, GB)

Access the full session

The future therapy of heart failure: shall we find the answers in the crystal ball?

Speakers: Professor J. McMurray, Professor T. McDonagh, Doctor S. Drakos, Professor J. Cleland

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Related content

ACVC Premium Access

Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention

18 March 2022

Open Access

Imaging in diagnosing hypertrophic obstructive cardiomyopathy.

30 August 2021

ESC Premium Access

Aortic stenosis and low flow state: implications for diagnosis and treatment.

27 August 2021

ESC 365 is supported by